m-peg-nhs ester

m-PEG-NHS ester (MW 10000) is a PEG-based PROTAC linker used for synthesizing PROTACs[1].

rm-PEG-NHS ester (MW 20000) is a PEG-based PROTAC linker utilized for the synthesis of PROTACs[1].

m-PEG-NHS ester (MW 5000) is a PEG-based PROTAC linker utilized in the synthesis of PROTACs[1].

m-PEG-NHS ester (MW 3400) can be used to modify active molecules, thereby enhancing their antigenicity and immunogenicity, which is beneficial for the preparation of injectable formulations. Its modification of serine protease lumbrokinase (LK) does not affect the enzyme’s strong fibrinolytic and thrombolytic activities, indicating promising application prospects.

m-PEG-NHS ester (MW 1000) can be used to modify active molecules and enhance their antigenicity and immunogenicity, which is beneficial for the preparation of injectable preparations. m-PEG-NHS ester modification of serine protease lumbrokinase (LK) does not affect its significant fibrinolytic and thrombolytic activities, showing good application prospects.

m-PEG-NHS ester (MW 550) is used to modify active molecules to enhance their antigenicity and immunogenicity, aiding in the preparation of injectable formulations. Modification with m-PEG-NHS ester does not affect the strong fibrinolytic and thrombolytic activities of the serine protease Lumbrokinase (LK), offering promising application potential.

m-PEG-NHS ester (MW 350) is utilized to modify active molecules, enhancing their antigenicity and immunogenicity, thus aiding in the preparation of injectable formulations. Modification of serine protease lumbrokinase (LK) with m-PEG-NHS ester does not affect its fibrinolytic and thrombolytic activities, indicating promising potential for application.

m-PEG-NHS ester (mPEG-SC) (MW 30000) is useful for modifying active molecules to enhance their antigenicity and immunogenicity, aiding in the formulation of injectable preparations. Modification of serine protease lumbrokinase (LK) with m-PEG-NHS ester does not affect its fibrinolytic and thrombolytic activities, indicating promising application potential.

m-PEG-NHS ester (MW 2000) is employed to modify active molecules, enhancing their antigenicity and immunogenicity, thereby aiding in the preparation of injectable formulations. Its modification of the serine protease lumbrokinase (LK) does not compromise its fibrinolytic and thrombolytic activities, indicating significant potential for application.

m-PEG8-NHS ester is an 8-unit PEG-containing ADC linker that can be used to synthesize antibody-coupled reactive molecules (ADCs), which can be used to modify proteins and peptides.

m-PEG12-NHS ester is a PEG backbone PROTAC linker commonly used in the synthesis of PROTAC molecules, and the NHS ester can covalently bind to primary amines (-NH2) on biomolecule.

m-PEG1-NHS ester, a polyethylene glycol (PEG)/alkyl/ether-based PROTAC linker, is utilized for the synthesis of PROTACs.

m-PEG3-NHS ester is a PEG-based linker essential for PROTACs, facilitating the conjugation of two vital ligands necessary for PROTAC formation, thereby enabling selective protein degradation via the ubiquitin-proteasome system within cells.

m-PEG4-NHS ester is a PEG-based linker for PROTACs that connects two essential ligands, facilitating selective protein degradation via the ubiquitin-proteasome system within cells.

m-PEG4-O-NHS ester is a PEG-based linker for PROTACs, facilitating the connection of two essential ligands critical for PROTAC molecule formation and enabling selective protein degradation via the ubiquitin-proteasome system within cells.

m-PEG5-NHS ester is a PEG-based linker used in PROTACs to connect two essential ligands, facilitating the formation of PROTAC molecules and enabling selective protein degradation through the ubiquitin-proteasome system within cells.

m-PEG6-NHS ester is a non-cleavable PEG linker consisting of 5 units, employed in the synthesis of antibody-drug conjugates (ADCs).

m-PEG7-NHS ester is a PEG-based linker for PROTACs, essential for joining two ligands crucial in forming PROTAC molecules. This linker facilitates selective protein degradation by utilizing the ubiquitin-proteasome system within cells.

m-PEG8-CH2CH2-NHS ester is a PEG--based PROTAC linker can be used in the synthesis of PROTACs.

NHS-PEG4-(m-PEG4)3-ester is a PEG-based PROTAC linker used for synthesizing PROTACs [1].

m-C-tri(CH2-PEG1-NHS ester) is a non-cleavable one-unit polyethylene glycol (PEG) linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

m-PEG-Lys-NHS ester (MW 20,000) is an alkyl/ether-based PROTAC linker commonly used in PROTAC synthesis[1].

m-PEG-Lys-NHS ester (MW 40000) is an alkyl/ether-based PROTAC linker used in the synthesis of PROTACs [1].

m-PEG10-NHS ester is a PEG-based linker for PROTACs that joins two essential ligands, crucial for forming PROTAC molecules, facilitating selective protein degradation by leveraging the ubiquitin-proteasome system [within cells].